SEC Form D · filed February 8, 2016
Apellis Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
David S. Watson · Crestwood, KYExecRobert S. Adelman · San Francisco, CADirectorDaniel S. Geffken · Crestwood, KYExecNicole S. Perry · Crestwood, KYExecFederico S. Grossi · Crestwood, KYExecBihua S. Chen · Boston, MADirectorPascal Deschatelets · Crestwood, KYExecAlec S. Machiels · Crestwood, KYDirectorA. S. Dunlop · Bethesda, MDDirectorStephanie S. O'Brien · Newton, MADirectorGerald S. Chan · Newton, MADirectorCedric J. Francois · Crestwood, KYExec · DirectorMichael Druga · RALEIGH, NCExecGregory M. Friedman · ATLANTA, GAExec · DirectorJoseph J. Glatt · Dublin 2, IrelandDirectorHoward Tullman · Chicago, ILExecNicholas R. Zelenczuk · Halifax, Z4ExecAlexander Allodi · Chicago, ILDirectorKevin Allodi · Chicago, ILExecMathew M. Crosswy · ATLANTA, GAExec · DirectorRobert M. Woomer · ATLANTA, GAExec · DirectorSs Hotel Credit Opportunity Fund, LLC · ATLANTA, GAExec · DirectorDavid Dworsky · Gardena, CADirectorStorm Venture Associates V, L.L.C · MENLO PARK, CADirectorDominic A. Bassani · Crestone, CODirectorRobin P. Selati · CHICAGO, ILDirectorRyan R. Selwood · Halifax, Z4ExecJoshua S. Phillips · Wakefield, MADirectorPhilip C. Wolf · Montreal, Quebec, CanadaExecSophie Forest · Montreal, Quebec, CanadaExecJeff C. Fagnan · Montreal, Quebec, CanadaExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗